Welcome to our dedicated page for Conx SEC filings (Ticker: CONXU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Conx's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Conx's regulatory disclosures and financial reporting.
CONX Corp filed a Form 12b-25 to notify that its Quarterly Report on Form 10-Q for the period ended June 30, 2025 will be late. The company cites ongoing work to complete its annual financial statements and audit following its cash purchase of a majority equity interest in Red Technologies SAS on December 5, 2024, which has delayed preparation of the unaudited condensed financial statements for this quarter.
CONX states it cannot file the 10-Q within the normal deadline without unreasonable effort or expense and expects it will be unable to file even within the standard 5-day extension. The company confirms that its Form 10-K for the year ended December 31, 2024 and Form 10-Q for the quarter ended March 31, 2025 also remain outstanding. It anticipates a significant change in results of operations in the upcoming 10-Q because it will reflect the completed Red Technologies acquisition, but says the financial statements are not far enough along to provide a reasonable estimate of those results.